A case report filed by scientists at The Pirbright Institute details the first instance of naturally acquired foot-and-mouth disease virus (FMDV) infection in dogs. In this highly unusual case reported in BMC Veterinary Research, FMDV was identified in a sample of heart tissue received by Pirbright’s diagnostic laboratory, the World Reference Laboratory for Foot-and-Mouth Disease (WRLFMD).
Early animal studies by Pirbright and Oxford yield promising results for new potential COVID-19 vaccine
Studies carried out by The Pirbright Institute and the University of Oxford have shown that Oxford’s new potential vaccine against COVID-19, named RBD-SpyVLP, produces a strong antibody response in mice and pigs, providing vital information for the further development of the vaccine. Although this type of vaccine is not a competitor for the first wave of vaccines, it is hoped that it will be useful as a standalone vaccine or as a booster for individuals primed with a different COVID-19 vaccine.